KCM
PHAR

Knoll Capital Management’s Pharming Group PHAR Stock Holding History

Knoll Capital Management’s Portfolio PHAR Stock Details PHAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$67.5K Buy
+4,057
New +$68.8K 0.04% 35

Other funds holding PHAR

SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SP
SmartHarvest Portfolios Poulsbo, Washington $240M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
LFG
Larson Financial Group St Louis, Missouri $3.13B AUM 22.88% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
SHIM
Stone House Investment Management Tunkhannock, Pennsylvania $558M AUM 14.72% 1-Year Est. Return

Knoll Capital Management's PHAR Position: Q1 2026 in Review

Knoll Capital Management opened a new position in Pharming Group (PHAR) in Q1 2026: 4,057 shares worth $67.5K. The stake represents 0.04% of the portfolio and ranks #35 among its holdings.

12 funds tracked by Wall St. Rank hold PHAR as of Q1 2026.

  • Knoll Capital Management held 4,057 shares of Pharming Group worth $67.5K as of Q1 2026.
  • Pharming Group was a new Knoll Capital Management position in Q1 2026.
  • Pharming Group made up 0.04% of Knoll Capital Management's portfolio in Q1 2026, its #35 holding.
  • 12 funds tracked by Wall St. Rank held Pharming Group as of Q1 2026.

Based on Knoll Capital Management's 13F filing for Q1 2026, filed 15 May 2026.